Cargando…
CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans
BACKGROUND: Chronic lymphocytic leukemia (CLL), the most common adulthood leukemia, is characterized by the accumulation of abnormal CD5(+) B lymphocytes, which results in a progressive failure of the immune system. Despite intense research efforts, drug resistance remains a major cause of treatment...
Autores principales: | Martinez-Torres, Ana-Carolina, Quiney, Claire, Attout, Tarik, Boullet, Heloïse, Herbi, Linda, Vela, Laura, Barbier, Sandrine, Chateau, Danielle, Chapiro, Elise, Nguyen-Khac, Florence, Davi, Frédéric, Le Garff-Tavernier, Magali, Moumné, Roba, Sarfati, Marika, Karoyan, Philippe, Merle-Béral, Hélène, Launay, Pierre, Susin, Santos A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348493/ https://www.ncbi.nlm.nih.gov/pubmed/25734483 http://dx.doi.org/10.1371/journal.pmed.1001796 |
Ejemplares similares
-
Small AntiMicrobial Peptide with In Vivo Activity Against Sepsis
por: Boullet, Héloise, et al.
Publicado: (2019) -
3-Substituted Prolines: From Synthesis to Structural Applications, from Peptides to Foldamers †
por: Mothes, Céline, et al.
Publicado: (2013) -
Functional assessment of p53 in chronic lymphocytic leukemia
por: Le Garff-Tavernier, M, et al.
Publicado: (2011) -
The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?
por: Bauvois, Brigitte, et al.
Publicado: (2023) -
Relation of Neutrophil Gelatinase-Associated Lipocalin Overexpression to the Resistance to Apoptosis of Tumor B Cells in Chronic Lymphocytic Leukemia
por: Bauvois, Brigitte, et al.
Publicado: (2020)